[Comparative assessment of the expression of Muc 2, Muc 5AC, and Muc 6 in serrated neoplasms of the colon].

Autor:	Mikhaleva LM; Research Institute of Human Morphology, Moscow, Russia; City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow, Russia., Vandysheva RA; Research Institute of Human Morphology, Moscow, Russia; City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow, Russia., Shakhpazyan NK; City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow, Russia., Fedorov ED; City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Biryukov AE; Research Institute of Human Morphology, Moscow, Russia; City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow, Russia., Midiber KY; City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow, Russia., Pechnikova VV; Research Institute of Human Morphology, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Arkhiv patologii [Arkh Patol] 2019; Vol. 81 (2), pp. 10-17.
DOI:	10.17116/patol20198102110
Abstrakt:	In the course of the serrated pathway of carcinogenesis, there are changes in the expression of mucins with a characteristic immunophenotypic sign, such as a late loss of intestinal differentiation and an increase in gastric differentiation. Objective: To comparatively assess the expression of Muc 2, Muc 5AC, and Muc 6 in hyperplastic polyps (HPs), sessile serrated adenomas (SSAs) and traditional serrated adenomas (TSAs) of the colon for determination of their role in differential diagnosis. Material and Methods: Sixty-five serrated masses from 52 patients were examined. Among them, there were 26 SSAs, 26 HPs, and 13 TSAs. A histological examination was done using hematoxylin and eosin staining; periodic acid-Schiff reaction in combination with alcian blue, as well as immunohistochemistry with anti-Muc 2, anti-Muc 5AC, and anti-Muc 6 antibodies were used. Genetic testing of the specimens for KRAS and BRAF mutations was also carried out. Results: All the serrated neoplasms of the colon exhibited a pronounced expression of Muc 2. A marked Muc 6 expression in the dilated crypt bases was found in 76.9% of SSAs, while no reaction was seen in 92.3% of HPs and in 100% of TSAs. SSAs were characterized by an intense Muc 5AC expression in the whole length of the crypts and in the surface epithelium in contrast with HPs and TSAs, where the expression of the marker was focal. Comparison of the response of the markers and the presence of gene mutations identified that the SSAs with BRAF mutation intensely expressed along the length of the crypt for Muc 5AC and Muc 6; and the TSAs with KRAS mutation had a moderate focal Muc 5AC expression in the crypt bases in 100% of cases. Conclusion: For differential diagnosis of the types of serrated adenomas of the colon, it is useful for a pathologist to apply the immunohistochemical markers Muc 2, Muc 5AC, and Muc 6 in his/her practice.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu